
A study investigated factors influencing cervical disease control in advanced thyroid cancer patients undergoing cervical external beam radiation therapy (EBRT). Cervical progression was associated with older age, greater lymph node involvement, and delayed EBRT post-surgery. Combining EBRT with multikinase inhibitors (MKIs) improved survival and local disease control. Performing EBRT before radioiodine (RAI) yielded longer cervical progression-free survival (CPFS) compared to RAI before EBRT. Younger age, fewer affected nodes, and early EBRT post-surgery were associated with better cervical disease control. Integrating EBRT with MKIs and testing for TERT mutations could refine patient selection for cervical EBRT, warranting further investigation.
Like
Save
Share